Structure characterization and performance evaluation of modified bovine pericardial scleral biological patch with genipin

doi:10.12307/2022.451

Abstract

Abstract: BACKGROUND: At present, the application of biological patch in posterior scleral reinforcement has received extensive attention. The structure and performance of the biological scleral mesh are directly related to the success rate of the implant, so it is very important to characterize the structure and evaluate the performance of the biological mesh.
OBJECTIVE: To investigate the structure and properties of the modified bovine pericardial scleral biological patch with genipin.
METHODS: The structures of fresh group, acellular group and genipin group were characterized by optical microscope, scanning electron microscopy, infrared spectrometer, and X-ray diffraction. Their physical index was evaluated through the determination of mechanical properties, water content rate and thermal stability. In addition, the biocompatibility of bovine pericardium patch in genipin group was evaluated by genetic toxicity test.
RESULTS AND CONCLUSION: (1) The results of histology and scanning electron microscopy showed that the cellular components in the material were effectively removed by acellular treatment. After acellular treatment and genipin modification, the collagen fiber structure was well preserved and orderly without destroying the stable structure of the collagen fiber. (2) Infrared spectrometer and X-ray diffraction demonstrated that there were more amide groups in the collagen fiber of bovine pericardium in genipin group. In addition, the crystal phase of bovine pericardium in fresh and acellular groups was incomplete and the crystallization was poor, while its crystallinity of genipin group was improved. (3) Tensile strength of bovine pericardium in genipin group was significantly higher than that of acellular group (P < 0.05); and elongation at break was significantly lower than that in acellular group (P < 0.05). (4) There was no significant difference in the water content rate between genipin group and acellular group (P > 0.05). (5) The temperature of thermal denaturation in genipin group was higher than that in acellular group. (6) The in vitro mammalian chromosome aberration test in genipin group showed negative result. (7) The results suggested that modified bovine pericardium patch for posterior scleral reinforcement with genipin had good physical and chemical properties and biocompatibility.

Key words: bovine pericardium, acellular, posterior scleral reinforcement, biological patch of eye sclera, genipin, modified, characteristics

CLC Number:

Liu Xiaojun, Li Zihong, Guo Wenyuan, Han Ying, Xu Yuyin, Zhou Jing, Wang Junmin. Structure characterization and performance evaluation of modified bovine pericardial scleral biological patch with genipin[J]. Chinese Journal of Tissue Engineering Research, 2022, 26(34): 5430-5435.

Figures/Tables 9

References

[1] KHOSHHAL F, HASHEMI H, HOOSHMAND E, et al. The prevalence of refractive errors in the Middle East: A systematic review and meta-analysis. Int Ophthalmol. 2020;40(3):1571-1586．
[2] 王素景.高度近视视网膜脱离患者对侧眼视网膜病变及激光治疗的效果[J].河南医学研究,2017,26(11):2011-2012.
[3] XIAO O, GUO X, WANG D, et al. Distribution and Severity of Myopic Maculopathy Among Highly Myopic Eye. Invest Ophth Vis Sci. 2018;59(12):4880-4885.
[4] 蔺琪,于刚,崔燕辉,等.改良四片式后巩膜加固术治疗儿童进行性高度近视临床研究[J].中国斜视与小儿眼科杂志,2016,24(3):27-28+26+61+5.
[5] 袁梦克,高新晓,魏航,等.病理性近视黄斑劈裂的黄斑区脉络膜厚度及相关影响因素[J].中华眼视光学与视觉科学杂志,2016,18(9):542-545.
[6] 刘亚妮,赵小莹,唐蓓,等.改良的后巩膜加固术治疗高度近视的疗效评估及护理[J].中国药物与临床,2020,20(3):483-485.
[7] LI X, YANG X, LI Q, et al. Posterior scleral reinforcement for the treatment of pathological myopia. Int J Ophthalmol. 2016;9(4):580-584.
[8] 陈珣,王晓瑛,周行涛,等.后巩膜加固术(PSR)后ICL植入术矫正成人高度近视的临床观察[J].复旦学报(医学版),2020,47(3):404-410.
[9] 胥静,谢立科,郝晓凤,等.后巩膜加固术实验研究及临床进展[J].中国医药导报,2019,16(32):42-46.
[10] 张景尚,万修华.后巩膜加固材料在高度近视眼手术治疗中的应用进展[J].国际眼科杂志,2019,19(1):59-62.
[11] 高婷婷,邴启斌,龙琴.后巩膜加固术研究新进展[J].临床眼科杂志, 2017,25(4):381-383.
[12] 过文泰,胡民辉,黄榕康,等.疝外科材料学百年发展及未来展望[J].中华胃肠外科杂志,2018,21(7):828-832.
[13] 王彦,刘德成.脱细胞牛心包补片在义眼台置换术中的应用[J].中华眼外伤职业眼病杂志,2017,39(7):545-548.
[14] 周希彬,黄一飞,吴志鸿,等.牛心包生物补片对后巩膜加固区的生物力学特性及其作用机制[J].武警医学,2015,26(6):609-612.
[15] 欧阳朝祜,褚仁远,赵梅,等.牛心包补片应用于后巩膜加固术的早期安全性与生物相容性[J].中华眼视光学与视觉科学杂志,2016,18(5): 259-263.
[16] 易姝,易娟,余时智.后巩膜加固术治疗青少年病理性近视的疗效观察[J].国际眼科杂志,2016,16(4):732-734.
[17] 王旻,笪琳萃,谢艳,等.京尼平作为交联剂在天然生物材料改性中的应用[J].中国修复重建外科杂志,2013,27(5):580-585.
[18] SUNG HW, HUANG RN, HUANG LL, et al. In vitro evlauation of cytotoxicity of a naturally occurring cross-linking reagent for biological tissue fixation. J Biomater Sci Polym Edn. 1999;10(1):63-78.
[19] 王建光,刘天起,王雪梅,等.京尼平与戊二醛鞣制牛心包材料的对比研究[J].山东大学学报(医学版),2011,49(5):24-28.
[20] 陈平,李新华,邢万红.京尼平交联的脱细胞牛心包生物支架材料的实验研究[J].中国医药导报,2010,7(6):28-30.
[21] 田聪,万荣欣,刘欣,等.生物交联剂京尼平交联牛心包生物支架材料的性能[J].中国生物医学工程学报,2011,30(2):281-286.
[22] 周希彬.牛心包生物补片应用于后巩膜加固术的实验研究[D].北京:军医进修学院,2012.
[23] 周小婷,周静,周岩,等.眼巩膜生物补片的亚慢性全身毒性试验研究[J].组织工程与重建外科杂志, 2020,16(6):462-466.
[24] 钟红荣,张岩,包红,等.丝素/明胶/壳聚糖支架材料的构建及表征[J].材料导报, 2018,32(22):3954-3960.
[25] 石敏,陶思洁,李丹,等.面向组织工程应用的再生丝素/海藻酸钙海绵:制备、表征及体内、体外性能研究[J].材料导报,2020,34(4):4158-4165.
[26] 晏飞燕,刘欣,万荣欣,等.牛心包脱细胞支架的制备研究[J].中国生物医学工程学报,2010,29(4): 607-613.
[27] YY/T 0870.2-2013 医疗器械遗传毒性试验第2部分：体外哺乳动物染色体畸变试验[S].
[28] 程祥,郭欢,刘燕萍,等.脱细胞异种生物外科补片的免疫原性[J].中国组织工程研究,2020,24(34):5564-5569.
[29] 赵亮,李霞飞,周坤,等.Triton-x100与丹参酚酸B制备脱细胞血管支架及其生物力学性能[J].中国组织工程研究,2019,23(6):951-956.
[30] 郑欣,但年华,陈一宁,等.胶原基生物补片及其抗钙化研究进展[J].生物医学工程与临床,2018,22(5):591-595．
[31] 李丽花,熊健,曹苹,等.改性化学交联脱细胞真皮基质材料的生物相容性[J].中国组织工程研究,2019,23(26):4206-4211.
[32] 肖宏涛,田社民,查新建,等.不同交联剂对脱细胞牛心包膜生物材料改性的实验研究[J].中国修复重建外科杂志,2015,29(10):1301-1306.
[33] 刘其静.单宁酸鞣制对牛心包材料的改性研究[D].武汉:华中农业大学，2019.
[34] 郭岗岗,庞亚博,杨建华,等.采用静电纺丝技术制备丝素纤维蛋白/聚已内酯临时肩袖补片[J].中国组织工程研究,2018,22(34):5501-5509.
[35] GAO S, YUAN Z, GUO W, et al.Comparison of glutaraldehyde and carbodiimides to crosslink tissue engineering scaffolds fabricated by decellularized porcine menisci. Mater Sci Eng C. 2017;71: 891-900.
[36] 潘腾飞,陶剑,蒋彩云,等.两种脱细胞支架原位植入转归动物试验研究[J].河北工业大学学报,2020,49(3):46-54.
[37] ANDREWS ME, MURALI J, MURALIDHARAN C, et al. Interaction of collagen with corilagin. Colloid Polym Sci. 2003;281(8):766-770.
[38] 刘淑萍,李亮,刘让同,等.羧甲基纤维素钠改性角蛋白膜的结构与性能[J].纺织学报,2019,40(6):14-19.
[39] LIU XH, DAN NH, DAN WH, et al. Feasibility study of the natural derived chitosan dialdehyde for chemical modification of collagen. Int J Biol Macromol. 2016;82:989-997.
[40] 白忠祥,但年华,但卫华,等.双醛羧甲基纤维素-胶原复合止血材料的研制[J].材料导报,2018,32(20):3628-3633.
[41] NICKERSON MT, PATEL J, HEYD DV, et al. Kinetic and mechanistic considerations in the gelation of genipin-crosslinked gelatin. Int J Biol Macromol. 2006; 39(4-5):298-302.
[42] 胡康,张伟.胶原蛋白作为医用生物材料对缺损组织修复、再生及重建的作用与意义[J].中国组织工程研究,2019,23(2):317-322.
[43] 陈晓松,张建,李建新.一种新型活组织材料的组织学及力学特性[J].中国组织工程研究,2013,17(34):6110-6115.
[44] ZHOU X, TAO Y, CHEN E, et al. Genipin-cross-linked type II collagen scaffold promotes the differentiation of adipose-derived stem cells into nucleus pulposus-like cells. J Biomed Mater Res A. 2018;106(5):1258-1268.
[45] GE TC, XING N, CHEN J, et al. Comparison among several foam dressings in the properties of water-absorption,water-locking and air permeability. Zhonghua Shao Shang Za Zhi. 2012;28 (5):349-352.
[46] 田振华,王颖.氧化羧甲基纤维素钠改性胶原膜的制备及表征[J].皮革科学与工程,2020,30(4):7-12.
[47] 高玲玲,侯成立,高远,等.胶原蛋白热稳定性研究进展[J].中国食品学报,2018,8(5):200-212.